Literature DB >> 22867087

N-acyl homoserine lactone mediated interspecies interactions between A. baumannii and P. aeruginosa.

Nidhi Bhargava1, Prince Sharma, Neena Capalash.   

Abstract

Acinetobacter baumannii and Pseudomonas aeruginosa are pathogens capable of colonizing the same infection sites and employing N-acyl homoserine lactone (AHL) based quorum-sensing systems to co-ordinate biofilm formation. Hence, the effect of P. aeruginosa AHLs on biofilm formation by A. baumannii and vice versa were investigated using the biofilm impaired quorum sensing mutants, A. baumannii M2 (abaI::Km) and P. aeruginosa PAO-JP2. Complementing the mutants with heterologous, extracted and pure AHLs increased biofilm mass significantly. The surface area coverage and biovolume also increased significantly as observed by confocal scanning laser microscopy which corroborated scanning electron microscope analysis. Autoinducer synthase gene promoters of A. baumannii, P( abaI)-lacZ, and P. aeruginosa, P( lasI)-lacZ, were induced (p < 0.05) by heterologous AHLs. Growth of A. baumannii was not inhibited by pyocyanin of P. aeruginosa which may allow their co-existence and interaction in the clinical setting, thereby affecting the severity of combined infections and therapeutic measures to control them.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867087     DOI: 10.1080/08927014.2012.714372

Source DB:  PubMed          Journal:  Biofouling        ISSN: 0892-7014            Impact factor:   3.209


  13 in total

1.  Multiplicity of Quorum Quenching Enzymes: A Potential Mechanism to Limit Quorum Sensing Bacterial Population.

Authors:  Shikha Koul; Vipin Chandra Kalia
Journal:  Indian J Microbiol       Date:  2016-11-23       Impact factor: 2.461

Review 2.  In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations.

Authors:  Stamatis Karakonstantis; Petros Ioannou; Diamantis D Kofteridis
Journal:  Infection       Date:  2022-01-04       Impact factor: 3.553

Review 3.  Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity.

Authors:  A M Richards; Y Abu Kwaik; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2014-09-27       Impact factor: 3.563

4.  Pyocyanin stimulates quorum sensing-mediated tolerance to oxidative stress and increases persister cell populations in Acinetobacter baumannii.

Authors:  Nidhi Bhargava; Prince Sharma; Neena Capalash
Journal:  Infect Immun       Date:  2014-06-02       Impact factor: 3.441

Review 5.  Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex.

Authors:  Stamatis Karakonstantis; Evangelos I Kritsotakis
Journal:  Infection       Date:  2021-07-14       Impact factor: 3.553

6.  Pharmacology of T2R Mediated Host-Microbe Interactions.

Authors:  Manoj Reddy Medapati; Anjali Y Bhagirath; Nisha Singh; Prashen Chelikani
Journal:  Handb Exp Pharmacol       Date:  2022

Review 7.  Burns and biofilms: priority pathogens and in vivo models.

Authors:  Evgenia Maslova; Lara Eisaiankhongi; Folke Sjöberg; Ronan R McCarthy
Journal:  NPJ Biofilms Microbiomes       Date:  2021-09-09       Impact factor: 7.290

8.  Cloning and expression of quorum sensing N-acyl-homoserine synthase (LuxI) gene detected in Acinetobacter baumannii.

Authors:  Farzan Modarresi; Omid Azizi; Mohammad Reza Shakibaie; Mohammad Motamedifar; Shahla Mansouri
Journal:  Iran J Microbiol       Date:  2016-04

Review 9.  Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments.

Authors:  Emmanuel C Eze; Hafizah Y Chenia; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

Review 10.  Development of quorum-based anti-virulence therapeutics targeting Gram-negative bacterial pathogens.

Authors:  Song Buck Tay; Wen Shan Yew
Journal:  Int J Mol Sci       Date:  2013-08-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.